Motco decreased its position in shares of Clorox Company (The) (NYSE:CLX) by 29.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,100 shares of the company’s stock after selling 460 shares during the period. Motco’s holdings in Clorox Company (The) were worth $147,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of CLX. OMERS ADMINISTRATION Corp purchased a new stake in Clorox Company (The) during the second quarter worth approximately $2,184,000. Buckingham Asset Management LLC boosted its stake in Clorox Company (The) by 3.7% in the second quarter. Buckingham Asset Management LLC now owns 1,935 shares of the company’s stock worth $258,000 after buying an additional 69 shares during the last quarter. Pacer Advisors Inc. boosted its stake in Clorox Company (The) by 8.3% in the second quarter. Pacer Advisors Inc. now owns 2,642 shares of the company’s stock worth $352,000 after buying an additional 203 shares during the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund boosted its stake in Clorox Company (The) by 21.3% in the second quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 23,763 shares of the company’s stock worth $3,166,000 after buying an additional 4,172 shares during the last quarter. Finally, Airain ltd purchased a new stake in Clorox Company (The) during the second quarter worth approximately $945,000. 71.26% of the stock is owned by institutional investors.

Clorox Company (NYSE CLX) opened at 137.37 on Wednesday. The firm has a 50 day moving average of $134.18 and a 200-day moving average of $134.70. The stock has a market cap of $17.73 billion, a PE ratio of 25.75 and a beta of 0.40. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76.

Clorox Company (The) (NYSE:CLX) last announced its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same quarter in the previous year, the company posted $1.30 earnings per share. The company’s revenue for the quarter was up 2.9% compared to the same quarter last year. On average, analysts expect that Clorox Company will post $5.68 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://www.thecerbatgem.com/2017/08/30/motco-has-147000-position-in-clorox-company-the-clx.html.

A number of research firms recently commented on CLX. Jefferies Group LLC reissued a “hold” rating and set a $137.00 target price (up previously from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. Barclays PLC reissued an “equal weight” rating and set a $136.00 target price (down previously from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. BMO Capital Markets set a $150.00 target price on shares of Clorox Company (The) and gave the company a “buy” rating in a research report on Thursday, August 3rd. Royal Bank Of Canada reissued a “hold” rating and set a $115.00 target price on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Finally, BidaskClub raised shares of Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research report on Monday, July 31st. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $129.05.

In other news, SVP Jon M. Balousek sold 9,223 shares of the business’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the completion of the transaction, the senior vice president now owns 20,614 shares of the company’s stock, valued at $2,862,666.18. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP James E. Foster sold 9,861 shares of the business’s stock in a transaction on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the transaction, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at approximately $3,056,777.19. The disclosure for this sale can be found here. Insiders own 0.74% of the company’s stock.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.